← Leaderboards
Grover P Miller
Vanderbilt University
$2,356,837
Attributed
$4,482,601
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $687.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,482,601 · 6
By mechanism
R01$4,251,529 · 3
P20$117,056 · 1
R03$76,500 · 1
F32$37,516 · 1
Top collaborators
- Sanjay Joshua Swamidass12 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Klarissa D Jackson$2,598,002
- Richard N Armstrong$5,651,682
- Marylyn D Ritchie$17,567,522
- Katherine Chanel Konvinse$100,858
- John Fang$668,203
Others in their field
Top investigators on “Drug Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$409,188,846
- Lawrence Corey · Fred Hutchinson Cancer Center$302,964,844
- Wafaa M. El-Sadr · Columbia University Health Sciences$291,216,450
- Constance Ann Benson · University Of California, San Diego$284,817,600
Research focus
Drug DevelopmentMetabolicReactionPharmaceutical PreparationsMetabolismDatabasesPatternChemical ModelsToxic EffectStructureMathematical ModelMachine LearningFoundationsExperimental StudyMediatingHepatotoxicityExanthemaDoseGene FunctionExposure ToImmunogenicImmunogenicityCessation Of LifeDrug Withdrawal
Grant awards (15)
Novel metabolic pathway for halogenated drugs of abuse$76,500
R03 · FY2025 · DA · contact PI
Systematic Discovery of Bioactivation-Associated Structural Alerts$369,432
R01 · FY2023 · GM
Systematic Discovery of Bioactivation-Associated Structural Alerts$374,783
R01 · FY2022 · GM
Systematic Discovery of Bioactivation-Associated Structural Alerts$375,910
R01 · FY2021 · GM
Systematic Discovery of Bioactivation-Associated Structural Alerts$395,313
R01 · FY2020 · GM
DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY$374,026
R01 · FY2019 · LM
Computationally modeling the impact of ontogeny on drug metabolic fate$313,125
R01 · FY2019 · LM · contact PI
DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY$374,026
R01 · FY2018 · LM
Computationally modeling the impact of ontogeny on drug metabolic fate$313,125
R01 · FY2018 · LM · contact PI
DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY$374,026
R01 · FY2017 · LM
Computationally modeling the impact of ontogeny on drug metabolic fate$313,125
R01 · FY2017 · LM · contact PI
DATA AND TOOLS FOR MODELING METABOLISM AND REACTIVITY$351,101
R01 · FY2016 · LM
Computationally modeling the impact of ontogeny on drug metabolic fate$323,537
R01 · FY2016 · LM · contact PI
AR COBRE: ELECTRON TRANSFER/OXIDATIVE PHOSPHORYLATION$117,056
P20 · FY2005 · RR
RATE LIMITING STEPS IN CYTOCHROME P450 CATALYSIS$37,516
F32 · FY2000 · GM